COVID-19 and coagulopathy

被引：20
|
作者：
Sarkar, Malay [1 ]
Madabhavi, Irappa, V [2 ,3 ,4 ]
Pham Nguyen Quy [5 ]
Govindagoudar, Manjunath B. [6 ]
机构：
[1] Indira Gandhi Med Coll, Dept Pulm Med, Shimla, Himachal Prades, India
[2] Kerudi Canc Hosp, Dept Med & Pediat Oncol, Bagalkot, Karnataka, India
[3] JN Med Coll, Dept Med Oncol, Belagavi, Karnataka, India
[4] Nanjappa Hosp, Dept Med Oncol, Shimoga, Karnataka, India
[5] Kyoto Miniren Cent Hosp, Dept Med Oncol, Kyoto, Japan
[6] Pt BD Sharma Postgrad Inst Med Sci, Dept Pulm & Crit Care, Rohtak, Haryana, India
来源：
CLINICAL RESPIRATORY JOURNAL | 2021年 / 15卷 / 12期
关键词：
COVID-19; endotheliitis; heparin; microthrombosis; thrombosis; CORONAVIRUS DISEASE 2019; MEDICAL PATIENTS; INNATE IMMUNITY; THROMBOPROPHYLAXIS; COAGULATION; RIVAROXABAN; INFECTION; HEPARIN; METAANALYSIS; PROPHYLAXIS;
D O I：
10.1111/crj.13438
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
The SARS-CoV-2 is a new coronavirus responsible for the COVID-19 disease and has caused the pandemic worldwide. A large number of cases have overwhelmed the healthcare system worldwide. The COVID-19 infection has been associated with a heightened risk of thromboembolic complications. Various mechanisms are leading to the high thrombotic risk in COVID-19 patients such as inflammation, endotheliitis, hyperviscosity, and hypercoagulability. We searched PubMed, EMBASE, and CINAHL from January 2020 to December 2020. We used the following search terms: COVID-19, coagulopathy, and thrombosis. We reviewed the epidemiology, clinical features, mechanisms, and treatment of COVID-19-associated coagulopathy.
引用
收藏
页码：1259 / 1274
页数：16
相关论文
共 50 条
  • [41] Lessons learnt from COVID-19 coagulopathy
    Thachil, Jecko
    [J]. EJHAEM, 2021, 2 (03): : 577 - 584
  • [42] Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19
    Violi, Francesco
    Ceccarelli, Giancarlo
    Cangemi, Roberto
    Alessandri, Francesco
    D'Ettorre, Gabriella
    Oliva, Alessandra
    Pastori, Daniele
    Loffredo, Lorenzo
    Pignatelli, Pasquale
    Ruberto, Franco
    Venditti, Mario
    Pugliese, Francesco
    Mastroianni, Claudio Maria
    [J]. CIRCULATION RESEARCH, 2020, 127 (03) : 400 - 401
  • [43] Coagulopathy of Dengue and COVID-19: Clinical Considerations
    Islam, Amin
    Cockcroft, Christopher
    Elshazly, Shereen
    Ahmed, Javeed
    Joyce, Kevin
    Mahfuz, Huque
    Islam, Tasbirul
    Rashid, Harunor
    Laher, Ismail
    [J]. TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (09)
  • [44] Thrombosis and coagulopathy in COVID-19: An illustrated review
    Levi, Marcel
    Hunt, Beverley J.
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (05) : 744 - 751
  • [45] Defibrotide in the COVID-19 coagulopathy: What is the timing?
    Maccio, Antonio
    Madeddu, Clelia
    Caocci, Giovanni
    Oppi, Sara
    La Nasa, Giorgio
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (11) : 3113 - 3115
  • [46] Coagulopathy in COVID-19 and anticoagulation clinical trials
    Zhang, Heng
    Lao, Qifang
    Zhang, Jue
    Zhu, Jieqing
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022, 35 (03)
  • [47] Involvement of the contact pathway in COVID-19 coagulopathy
    Capecchi, M.
    Novembrino, C.
    Abbattista, M.
    Boscolo, M.
    Griffini, S.
    Grovetti, E.
    Gualtierotti, R.
    Cugno, M.
    Peyvandi, F.
    [J]. SWISS MEDICAL WEEKLY, 2023, 153 : 62S - 62S
  • [48] Re: COVID-19 Coagulopathy: Considerations for Urologists
    Cai, Tommaso
    Tandogdu, Zafer
    Wagenlehner, Florian M. E.
    Johansen, Truls E. Bjerklund
    [J]. JOURNAL OF UROLOGY, 2020, 204 (04): : 847 - 848
  • [49] COVID-19 coagulopathy: is it disseminated intravascular coagulation?
    Marcel Levi
    Toshiaki Iba
    [J]. Internal and Emergency Medicine, 2021, 16 : 309 - 312
  • [50] COVID-19 coagulopathy: is it disseminated intravascular coagulation?
    Levi, Marcel
    Iba, Toshiaki
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (02) : 309 - 312
12345